SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis - Concepedia

Concepedia

Publication | Open Access

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

DOI Full Paper Access

243

Citations

39

References

2011

Year

Joseph P. Ritchie, Vishnu C. Ramani, Yongsheng Ren, Annamaria Naggi, Giangiacomo Torri, Benito Casu, Sergio Penco, Claudio Pisano, Paolo Carminati, Monica Tortoreto,

Clinical Cancer Research

Abstract

These results provide mechanistic insight into the antitumor action of SST0001 and validate its use as a novel therapeutic tool for treating multiple myeloma.

References

	Year	Citations

Page 1